US, European IP chiefs applaud eased pharma patent rules in Argentina
By Nick Robertson ( October 27, 2026, 20:04 GMT | Insight) -- Patent office leaders from the US, Spain and Denmark were in Buenos Aires on Tuesday to celebrate the removal of Argentine patent regulations that limited the patent eligibility and patentability of follow-on innovations in the pharmaceuticals industry. The regulatory rescissions follow intellectual property commitments in a trade deal with the US early this year, and are a boon for the country’s pharma industry, the leaders said.Recent pharmaceutical patent regulation changes in Argentina will help the country’s pharmaceutical industry and bring its patent system closer to international practice, leaders of the US, Spanish and Danish patent offices said at an event in Buenos Aires on Tuesday.*...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.